Formulation and Evaluation of Pravastatin Sodium-Loaded PLGA Nanoparticles: In vitro–in vivo Studies Assessment

References

• Korani S, Korani M, Bahrami S, et al. Application of nanotechnology to improve the therapeutic benefits of statins. Drug Discov Today. 2019;24(2):567–574. doi:10.1016/j.drudis.2018.09.023
   PubMed Web of Science ®Google Scholar
• Castañeda PS, Escobar-Chávez JJ, Vázquez JA, Cruz IMR, Contreras LMM. Pravastatin transdermal patches: effect of the formulation and two different lengths of microneedles on in-vitro percutaneous absorption studies. Iran J Pharm Res. 2020;19(2):127–133. doi:10.22037/ijpr.2019.1100914
   PubMed Web of Science ®Google Scholar
• Al-Badr AA, Mostafa GA. Pravastatin sodium. Profiles Drug Subst Excip Relat Methodol. 2014;39:433–513. doi:10.1016/b978-0-12-800173-8.00008-8
   PubMedGoogle Scholar
• Campos‐Lara M, Pinto‐Almazán R, Oropeza MV, Mendoza‐Espinoza JA. Optimization of a pravastatin quantification method using HPLC with ultraviolet detection in human serum for monitoring dyslipidemic patients. J Liq Chromatogr. 2008;31(5):667–674. doi:10.1080/10826070701853784
   Web of Science ®Google Scholar
• Saraogi GK, Tholiya S, Mishra Y, et al. Formulation development and evaluation of pravastatin-loaded nanogel for hyperlipidemia management. Gels. 2022;8(2):81. doi:10.3390/gels8020081
   PubMed Web of Science ®Google Scholar
• Tayel SA, El-Nabarawi MA, Tadros MI, Abd-Elsalam WH. Duodenum-triggered delivery of pravastatin sodium via enteric surface-coated nanovesicular spanlastic dispersions: development, characterization and pharmacokinetic assessments. Int J Pharm. 2015;483(1–2):77–88. doi:10.1016/j.ijpharm.2015.02.012
   PubMed Web of Science ®Google Scholar
• Puttegowda VD, Karki R, Goli D, Mudagal MP, Mudagal MP. Formulation and pharmacokinetic evaluation of microcapsules containing pravastatin sodium using rats. Scientifica. 2016;2016:7623193. doi:10.1155/2016/7623193
   PubMedGoogle Scholar
• Moshiri M, Mehmannavaz F, Hashemi M, Yazdian-Robati R, Shabazi N, Etemad L. Evaluation of the efficiency of simvastatin loaded PLGA nanoparticles against acute paraquat-intoxicated rats. Eur J Pharm Sci. 2022;168:106053. doi:10.1016/j.ejps.2021.106053
   PubMed Web of Science ®Google Scholar
• Rizvi SZH, Shah FA, Khan N, et al. Simvastatin-loaded solid lipid nanoparticles for enhanced anti-hyperlipidemic activity in hyperlipidemia animal model. Int J Pharm. 2019;560:136–143. doi:10.1016/jijpharm.2019.02.002
   PubMed Web of Science ®Google Scholar
• Arafa MG, Girgis GN, El-Dahan MS. Chitosan-coated PLGA nanoparticles for enhanced ocular anti-inflammatory efficacy of atorvastatin calcium. Int J Nanomedicin. 2020;15:1335. doi:10.2147/IJN.S237314
   PubMed Web of Science ®Google Scholar
• Aldalaen S, El-Gogary RI, Nasr M. Fabrication of rosuvastatin-loaded polymeric nanocapsules: a promising modality for treating hepatic cancer delineated by apoptotic and cell cycle arrest assessment. Drug Dev Indu Pharm. 2019;45(1):55–62. doi:10.1080/03639045.2018.1515221
   PubMed Web of Science ®Google Scholar
• Sifaoui I, Díaz-Rodríguez P, Rodríguez-Expósito RL, et al. Pitavastatin loaded nanoparticles: a suitable ophthalmic treatment for Acanthamoeba Keratitis inducing cell death and autophagy in Acanthamoeba polyphaga. Eur J Pharm Biopharm. 2022;180:11–22. doi:10.1016/j.ejpb.2022.09.020
   PubMed Web of Science ®Google Scholar
• Derman S. Caffeic acid phenethyl ester loaded PLGA nanoparticles: effect of various process parameters on reaction yield, encapsulation efficiency, and particle size. J Nanomater. 2015;2015:341848. doi:10.1155/2015/341848
   Web of Science ®Google Scholar
• Sanna V, Roggio AM, Siliani S, et al. Development of novel cationic chitosan-and anionic alginate-coated poly(D, L-lactide-co-glycolide) nanoparticles for controlled release and light protection of resveratrol. Int J Nanomedicine. 2012;7:5501–5516. doi:10.2147/ijn.S36684
   PubMed Web of Science ®Google Scholar
• Kim BS, Kim CS, Lee KM. The intracellular uptake ability of chitosan-coated Poly (D, L-lactide-co-glycolide) nanoparticles. Arch Pharm Res. 2008;31(8):1050–1054. doi:10.1007/s12272-001-1267-5
   PubMed Web of Science ®Google Scholar
• Almutairy BK, Alshetaili A, Alali AS, Ahmed MM, Anwer MK, Aboudzadeh MA. Design of olmesartan medoxomil-loaded nanosponges for hypertension and lung cancer treatments. Polymers. 2021;13(14):2272. doi:10.3390/polym13142272
   PubMed Web of Science ®Google Scholar
• Anwer MK, Al-Mansoor MA, Jamil S, Al-Shdefat R, Ansari MN, Shakeel F. Development and evaluation of PLGA polymer based nanoparticles of quercetin. Int J Biol Macromol. 2016;92:213–219. doi:10.1016/j.ijbiomac.2016.07.002
   PubMed Web of Science ®Google Scholar
• Ramadan E, Borg T, Abdelghani G, Saleh NM. Transdermal microneedle-mediated delivery of polymeric lamivudine-loaded nanoparticles. J Pharm Technol Drug Res. 2016;5:1. doi:10.7243/2050-120X-5-1
   Google Scholar
• Bhatt PC, Verma A, Al-Abbasi FA, Anwar F, Kumar V, Panda BP. Development of surface-engineered PLGA nanoparticulate-delivery system of Tet1-conjugated nattokinase enzyme for inhibition of Aβ(40) plaques in Alzheimer’s disease. Int J Nanomedicine. 2017;12:8749–8768. doi:10.2147/ijn.S144545
   PubMed Web of Science ®Google Scholar
• Iqbal M, Zafar N, Fessi H, Elaissari A. Double emulsion solvent evaporation techniques used for drug encapsulation. Int J Pharm. 2015;496(2):173–190. doi:10.1016/j.ijpharm.2015.10.057
   PubMed Web of Science ®Google Scholar
• El-Emam GA, Girgis GN, Hamed MF, Soliman O, Abd El AE. Formulation and pathohistological study of mizolastine–solid lipid nanoparticles–loaded ocular hydrogels. Int J Nanomedicine. 2021;16:7775. doi:10.2147/IJN.s335482
   PubMed Web of Science ®Google Scholar
• Vyas A, Saraf SK, Saraf S. Encapsulation of cyclodextrin complexed simvastatin in chitosan nanocarriers: a novel technique for oral delivery. J Incl Phenom Macrocycl Chem. 2010;66:251–259. doi:10.1007/s10847-009-9605-y
   Web of Science ®Google Scholar
• Badran MM, Harisa GI, AlQahtani SA, Alanazi FK, Zoheir KM. Pravastatin-loaded chitosan nanoparticles: formulation, characterization and cytotoxicity studies. JDDST. 2016;32:1–9. doi:10.1016/j.jddst.2016.01.004
   Web of Science ®Google Scholar
• Kang JH, Chon J, Kim YI, et al. Preparation and evaluation of tacrolimus-loaded thermosensitive solid lipid nanoparticles for improved dermal distribution. Int J Nanomedicine. 2019;14:5381–5396. doi:10.2147/ijn.S215153
   PubMed Web of Science ®Google Scholar
• Yamunappa KR, Suvarna P, Suvarna P, Swamy VB, Swamy VN. Formulation and evaluation of immediate release pravastatin sodium tablets. RJPDFT. 2016;8:105. doi:10.5958/0975-4377.2016.00014.8
   Google Scholar
• Martin AN, Bustamante P, Chun AHC. Physical Pharmacy: Physical Chemical Principles in the Pharmaceutical Sciences. 4th ed. Philadelphia (Pa): Lea & Febiger; 1993:284–323.
   Google Scholar
• Higuchi T. Mechanism of sustained-action medication. Theortical analysis of rate of release of solid drugs dispersed in solid matrix. J Pharm Sci. 1963;52:1145–1149. doi:10.1002/jps.2600521210
   PubMed Web of Science ®Google Scholar
• Ritger PL, Peppas NA. A simple equation for description of solute release I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J Control Release. 1987;5:23–36. doi:10.1016/0168-3659(87)90034-4
   Google Scholar
• Zou W, Cao G, Xi Y, Zhang N. New approach for local delivery of rapamycin by bioadhesive PLGA-carbopol nanoparticles. Drug Deliv. 2009;16(1):15–23. doi:10.1080/10717540802481307
   PubMed Web of Science ®Google Scholar
• Fathi HA, Allam A, Elsabahy M, Fetih G, El-Badry M. Nanostructured lipid carriers for improved oral delivery and prolonged antihyperlipidemic effect of simvastatin. Colloids Surf B. 2018;162:236–245. doi:10.1016/j.colsurfb.2017.11.064
   PubMed Web of Science ®Google Scholar
• Dalaklioglu S, Sahin P, Tasatargil A, Celik-Ozenci C. Pravastatin improves the impaired nitric oxide-mediated neurogenic and endothelium-dependent relaxation of corpus cavernosum in aged rats. Aging Male. 2014;17(4):259–266. doi:10.3109/13685538.2013.832194
   PubMed Web of Science ®Google Scholar
• Cocchetto DM, Bjornsson TD. Methods for vascular access and collection of body fluids from the laboratory rat. J Pharm Sci. 1983;72(5):465–492. doi:10.1002/jps.2600720503
   PubMed Web of Science ®Google Scholar
• Abo-zalam HB, El-Denshary ES, Abdelsalam RM, Khalil IA, Khattab MM, Hamzawy MA. Therapeutic advancement of simvastatin-loaded solid lipid nanoparticles (SV-SLNs) in treatment of hyperlipidemia and attenuating hepatotoxicity, myopathy and apoptosis: comprehensive study. Biomed Pharmacother. 2021;139:111494. doi:10.1016/j.biopha.2021.111494
   PubMed Web of Science ®Google Scholar
• Salem HF, Kharshoum RM, Abou-Taleb HA, Naguib DM. Brain targeting of resveratrol through intranasal lipid vesicles labelled with gold nanoparticles: in vivo evaluation and bioaccumulation investigation using computed tomography and histopathological examination. J Drug Target. 2019;27(10):1127–1134. doi:10.1080/1061186X.2019.1608553
   PubMed Web of Science ®Google Scholar
• Bancroft JD, Gamble M. Theory and Practice of Histological Techniques. Elsevier health sciences; 2008.
   Google Scholar
• Crotts G, Park TG. Protein delivery from poly(lactic-co-glycolic acid) biodegradable microspheres: release kinetics and stability issues. J Microencapsul. 1998;15(6):699–713. doi:10.3109/02652049809008253
   PubMed Web of Science ®Google Scholar
• Sinha V, Trehan A. Biodegradable microspheres for protein delivery. J Control Release. 2003;90(3):261–280. doi:10.1016/s0168-3659(03)00194-9
   PubMed Web of Science ®Google Scholar
• Nakhare S, Vyas SP. Preparation and characterization of multiple emulsion based systems for controlled diclofenac sodium release. J Microencapsul. 1996;13(3):281–292. doi:10.3109/02652049609026016
   PubMed Web of Science ®Google Scholar
• Panigrahi D, Sahu PK, Swain S, Verma RK. Quality by design prospects of pharmaceuticals application of double emulsion method for PLGA loaded nanoparticles. SN Appl Sci. 2021;3(6):638. doi:10.1007/s42452-021-04609-1
   Web of Science ®Google Scholar
• Feczkó T, Toth J, Dósa G, Gyenis J. Influence of process conditions on the mean size of PLGA nanoparticles. Chem Eng Process. 2011;50:846–853. doi:10.1016/j.cep.2011.05.006
   Web of Science ®Google Scholar
• Tefas LR, Tomuţă I, Achim M, Vlase L. Development and optimization of quercetin-loaded PLGA nanoparticles by experimental design. Clujul Med. 2015;88(2):214–223. doi:10.15386/cjmed-418
   PubMedGoogle Scholar
• Jalil R, Nixon JR. Biodegradable poly(lactic acid) and poly(lactide-co-glycolide) microcapsules: problems associated with preparative techniques and release properties. J Microencapsul. 1990;7(3):297–325. doi:10.3109/02652049009021842
   PubMed Web of Science ®Google Scholar
• Kheradmandnia S, Vasheghani-Farahani E, Nosrati M, Atyabi F. The effect of process variables on the properties of ketoprofen loaded solid lipid nanoparticles of beeswax and carnauba wax. IJCCE. 2010;29(4):181–187. doi:10.30492/ijcce.2010.6485
   Google Scholar
• Sznitowska M, Wolska E, Baranska H, Cal K, Pietkiewicz J. The effect of a lipid composition and a surfactant on the characteristics of the solid lipid microspheres and nanospheres (SLM and SLN). Eur J Pharm Biopharm. 2017;110:24–30. doi:10.1016/j.ejpb.2016.10.023
   PubMed Web of Science ®Google Scholar
• Misra PK, Dash U, Maharana S. Investigation of bovine serum albumin-surfactant aggregation and its physicochemical characteristics. Colloids Surf A. 2015;483:36–44. doi:10.1016/j.colsurfa.2015.06.052
   Google Scholar
• Wang B, Chen G, Mao Z, Zhang Y, Yu D, Gao C. Preparation and cellular uptake of PLGA particles loaded with lamivudine. Chin Sci Bull. 2012;57(31):3985–3993. doi:10.1007/s11434-012-5419-1
   Google Scholar
• Liang Q, Xiang H, Li X, et al. Development of rifapentine-loaded PLGA-based nanoparticles: in vitro characterisation and in vivo study in mice. Int J Nanomedicine. 2020;15:7491–7507. doi:10.2147/IJN.S257758
   PubMed Web of Science ®Google Scholar
• Elsewedy HS, Dhubiab BEA, Mahdy MA, Elnahas HM. Development, optimization, and evaluation of PEGylated brucine-loaded PLGA nanoparticles. Drug Deliv. 2020;27(1):1134–1146. doi:10.1080/10717544.20201797237
   PubMed Web of Science ®Google Scholar
• Tayel SA, El-Nabarawi MA, Tadros MI, Abd-Elsalam WH. Duodenum-triggered delivery of pravastatin sodium: II. Design, appraisal and pharmacokinetic assessments of enteric surface-decorated nanocubosomal dispersions. Drug Deliv. 2016;23(9):3266–3278. doi:10.3109/10717544.2016.1172367
   PubMed Web of Science ®Google Scholar
• Mehanna MM, Shabarek MI, Elmaradny HA, Elmartadny HA. Spray-dried pH-sensitive microparticles: effectual methodology to ameliorate the bioavailability of acid labile pravastatin. Drug Dev Ind Pharm. 2019;45(3):485–497. doi:10.1080/03639045.2018.1562465
   PubMed Web of Science ®Google Scholar
• Abd El Hady WE, Mohamed EA, Soliman OAE, El-Sabbagh HM. In vitro-in vivo evaluation of chitosan-PLGA nanoparticles for potentiated gastric retention and anti-ulcer activity of diosmin. Int J Nanomedicine. 2019;14:7191–7213. doi:10.2147/ijn.S213836
   PubMed Web of Science ®Google Scholar
• Dilawar N, Ur-Rehman T, Shah KU, Fatima H, Alhodaib A. Development and evaluation of PLGA nanoparticle-loaded organogel for the transdermal delivery of risperidone. Gels. 2022;8(11):709. doi:10.3390/gels8110709
   PubMed Web of Science ®Google Scholar
• Huang Y, Hu L, Huang S, et al. Curcumin-loaded galactosylated BSA nanoparticles as targeted drug delivery carriers inhibit hepatocellular carcinoma cell proliferation and migration. Int J Nanomedicine. 2018;13:8309. doi:10.2147/IJN.S184379
   PubMed Web of Science ®Google Scholar
• Akl M, Kartal-Hodzic A, Oksanen T, et al. Factorial design formulation optimization and in vitro characterization of curcumin-loaded PLGA nanoparticles for colon delivery. JDDST. 2016;32. doi:10.1016/j.jddst.2016.01.007
   Google Scholar
• Michnik A. Thermal stability of bovine serum albumin DSC study. J Therm Anal Calorimetry. 2003;71(2):509–519. doi:10.1023/A:1022851809481
   Web of Science ®Google Scholar
• Öztürk AA, Yenilmez E, Özarda MG. Clarithromycin-loaded poly (lactic-co-glycolic acid) (PLGA) nanoparticles for oral administration: effect of polymer molecular weight and surface modification with chitosan on formulation, nanoparticle characterization and antibacterial effects. Polymers. 2019;11(10):1632. doi:10.3390/polym11101632
   PubMed Web of Science ®Google Scholar
• Abdelghany S, Parumasivam T, Pang A, et al. Alginate modified-PLGA nanoparticles entrapping amikacin and moxifloxacin as a novel host-directed therapy for multidrug-resistant tuberculosis. JDDST. 2019;52:642–651. doi:10.1016/j.jddst.2019.05.025
   Web of Science ®Google Scholar
• Yurtdaş Kirimlioğlu G, Öztürk AA. Levocetirizine dihydrochloride-loaded chitosan nanoparticles: formulation and in vitro evaluation. Turk J Pharm Sci. 2020;17(1):27–35. doi:10.4274/tjps.galenos.2018.34392
   PubMed Web of Science ®Google Scholar
• Yadav P, Yadav AB. Preparation and characterization of BSA as a model protein loaded chitosan nanoparticles for the development of protein-/peptide-based drug delivery system. Futur J Pharm Sci. 2021;7(1):200. doi:10.1186/s43094-021-00345-w
   Web of Science ®Google Scholar
• Ruiz-Picazo A, Colón-Useche S, Perez-Amorós B, et al. Investigation to explain bioequivalence failure in pravastatin immediate-release products. Pharmaceutics. 2019;11(12):663. doi:10.3390/pharmaceutics11120663
   PubMed Web of Science ®Google Scholar
• Kumar Y, Philip B, Pathak K. High-efficiency loading and controlled release of highly water-soluble drug, pravastatin sodium by use of cross-linked β-cyclodextrin. Int J Pharm Investig. 2011;1(1):10–16. doi:10.4103/2230-973X.76722
   PubMedGoogle Scholar
• Puri V, Chaudhary KR, Singh A, Singh C. Inhalation potential of N-Acetylcysteine loaded PLGA nanoparticles for the management of tuberculosis: in vitro lung deposition and efficacy studies. Curr Res Pharmacol Drug Discov. 2022;3:100084. doi:10.1016/j.crphar.2022.100084
   PubMedGoogle Scholar
• Govender T, Stolnik S, Garnett MC, Illum L, Davis SS. PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug. J Control Release. 1999;57(2):171–185. doi:10.1016/S0168-3659(98)00116-3
   PubMed Web of Science ®Google Scholar
• Alenazi ASM, El-Bagory IM, Yassin AB, et al. Design of polymeric nanoparticles for oral delivery of capreomycin peptide using double emulsion technique: impact of stress conditions. JDDST. 2022;71:103326. doi:10.1016/j.jddst.2022.103326
   Web of Science ®Google Scholar
• González AE. Colloidal aggregation coupled with sedimentation: a comprehensive overview. Adv Colloid Sci. 2016;211. doi:10.5772/65699
   Google Scholar
• Marinelli L, Ciulla M, Ritsema JAS, et al. Preparation, characterization, and biological evaluation of a hydrophilic peptide loaded on PEG-PLGA nanoparticles. Pharmaceutics. 2022;14(9):1821. doi:10.3390/pharmaceutics14091821
   PubMed Web of Science ®Google Scholar
• De S, Robinson DH. Particle size and temperature effect on the physical stability of PLGA nanospheres and microspheres containing Bodipy. AAPS PharmSciTech. 2004;5(4):e53. doi:10.1208/pt050453
   PubMed Web of Science ®Google Scholar
• Şengel-Türk CT, Hasçiçek C, Dogan AL, Esendagli G, Guc D, Gönül N. Preparation and in vitro evaluation of meloxicam-loaded PLGA nanoparticles on HT-29 human colon adenocarcinoma cells. Drug Dev Ind Pharm. 2012;38(9):1107–1116. doi:10.3109/03639045.2011.641562
   PubMed Web of Science ®Google Scholar
• Grundy SM. Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome. Am J Cardiol. 1998;81(4):18B–25B. doi:10.1016/S0002-9149(98)00033-2
   PubMedGoogle Scholar
• Harvey RA, Clark M, Finkel R, Rey J, Whalen K. Lippincott’s Illustrated Reviews: Pharmacology. Vol. 526. Philadelphia: Wolters kluwer india Pvt Ltd; 2012.
   Google Scholar
• Ahmed TA. Study the pharmacokinetics, pharmacodynamics and hepatoprotective activity of rosuvastatin from drug loaded lyophilized orodispersible tablets containing transfersomes nanoparticles. JDDST. 2021;63:102489. doi:10.1016/j.jddst.2021.102489
   Web of Science ®Google Scholar
• Dudhipala NR, Ettireddy SR, Puchakayala GR. Attenuation of lipid levels in triton induced hyperlipidemia rats through rosuvastatin calcium nanoparticles: pharmacokinetic and pharmacodynamic studies. Chem Phys Lipids. 2021;237:105081. doi:10.1016/j.chemphyslip.2021.105081
   PubMed Web of Science ®Google Scholar
• Soni A, Dandagi P, Gadad A, Mastiholimath V. Simvastatin-loaded PLGA nanoparticles for improved oral bioavailability and sustained release: effect of formulation variables. Asian J Pharm Sci. 2011;5:57. doi:10.4103/0973-8398.84545
   Google Scholar
• Assy N, Kaita K, Mymin D, Levy C, Rosser B, Minuk G. Fatty infiltration of liver in hyperlipidemic patients. Dig Dis Sci. 2000;45(10):1929–1934. doi:10.1023/a:1005661516165
   PubMed Web of Science ®Google Scholar
• Park EO, Bae EJ, Park BH, Chae SW. The associations between liver enzymes and cardiovascular risk factors in adults with mild dyslipidemia. J Clin Med. 2020;9(4). doi:10.3390/jcm9041147
   Web of Science ®Google Scholar
• Mahmoud MO, Aboud HM, Hassan AH, Ali AA, Johnston TP. Transdermal delivery of atorvastatin calcium from novel nanovesicular systems using polyethylene glycol fatty acid esters: ameliorated effect without liver toxicity in poloxamer 407-induced hyperlipidemic rats. J Control Release. 2017;254:10–22. doi:10.1016/j.jconrel.2017.03.039
   PubMed Web of Science ®Google Scholar
• Addison O, Marcus RL, LaStayo PC, Ryan AS. Intermuscular fat: a review of the consequences and causes. Int J Endocrinol. 2014;2014:309570. doi:10.1155/2014/309570
   PubMed Web of Science ®Google Scholar